tiprankstipranks
Trending News
More News >
Ensysce Biosciences (ENSC)
NASDAQ:ENSC
US Market
Advertisement

Ensysce Biosciences (ENSC) Income Statement

Compare
284 Followers

Ensysce Biosciences Income Statement

Last quarter (Q1 2025), Ensysce Biosciences's total revenue was $1.32M, an increase of 331.76% from the same quarter last year. In Q1, Ensysce Biosciences's net income was $-1.95M. See Ensysce Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 5.21M$ 2.23M$ 2.52M$ 3.53M$ 3.93M
Gross Profit
$ 5.21M$ -5.36M$ -17.31M$ 3.53M$ 2.56M
Operating Expenses
$ 4.72M$ 5.36M$ 6.91M$ 18.71M$ 1.61M
Depreciation and Amortization
$ 4.00$ -3.00$ 151.00$ 151.00$ 201.00
EBITDA
$ -6.73M$ -10.72M$ -24.22M$ -19.87M$ -1.61M
Operating Income
$ -6.73M$ -10.72M$ -24.22M$ -19.87M$ -1.61M
Other Income/Expenses
$ -1.26M$ 91.91K$ 14.41K$ -9.28M$ 1.45M
Pretax Income
$ -7.99M$ -10.63M$ -24.21M$ -29.15M$ -161.00K
Net Income
$ -7.99M$ -10.61M$ -24.17M$ -29.08M$ 56.77K
Per Share Metrics
Basic EPS
$ -4.57$ -4.69$ -139.44$ -355.68$ 0.56
Diluted EPS
$ -4.57$ -4.69$ -139.44$ -346.90$ 0.56
Weighted Average Shares Outstanding
1.75M 2.26M 179.93K 84.02K 4.46M
Weighted Average Shares Outstanding (Diluted)
1.75M 2.26M 179.93K 84.02K 6.37M
Currency in USD

Ensysce Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis